Company AB Science

AB

FR0010557264

Pharmaceuticals

Market Closed - Euronext Paris 11:55:00 2026-11-03 EST			After hours 15:59:58
0.5280 ^EUR	-2.04%		0.5270	-0.19%

10-09	AB Science S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
10-05	Weekly earnings calendar: PepsiCo kicks off the quarterly marathon

Business description: AB Science

AB Science specializes in research, development, and sales of kinase protein inhibitors (KPI), therapeutic drugs used in treating cancerous tumors, inflammatory and neuro-degenerative diseases in both humans and animals.

Number of employees: 33

Sales by Activity: AB Science

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Pharmaceuticals	1.61M	958K	970K	1.07M	1.17M

See all business segments

Geographical breakdown of sales: AB Science

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Europe	-	-	-	-	955K
outside Europe	-	-	-	-	219K

See all geographic segments

Executive Committee: AB Science

Manager	Title	Age	Since
Stéphane Ledermann CEO	Chief Executive Officer	-	2026-07-06
Laurent Guy DFI	Director of Finance/CFO	-	2009-11-19
Christian Fassotte CTO	Chief Tech/Sci/R&D Officer	-	2018-03-31
Alexis Bernard PRN	Corporate Officer/Principal	-	-

See AB SCIENCE governance

Composition of the Board of Directors: AB Science

Director	Title	Age	Since
Alain Moussy CHM	Chairman	-	2001-07-10
Patrick Moussy BRD	Director/Board Member	-	2011-09-19
Cécile de Guillebon BRD	Director/Board Member	65	2021-06-26
Catherine Johnston-Roussillon BRD	Director/Board Member	68	2021-06-26
Guillemette Latscha BRD	Director/Board Member	-	2021-06-26
Stéphane Ledermann CHM	Chairman	-	2026-07-06

Composition of the Board of Directors

Shareholders: AB Science

Name	Stocks	%	Valuation
Jean-Claude Marian 26.86 %	25,932,042	26.86 %	17 M €
Gestys SA 0.0155 %	15,000	0.0155 %	10 052 €
UBS Wealth Management SGIIC SA 0.003211 %	3,100	0.003211 %	2 077 €

Name	Stocks	%	Valuation
Friedland Gestion SAS 5.198 %	85,471	5.198 %	32 425 €

Name	Stocks	%	Valuation
Friedland Gestion SAS 4.167 %	64,103	4.167 %	19 950 €

List of AB SCIENCE shareholders

Company details: AB Science

AB Science SA

3, avenue George V

75008, Paris

+33 1 47 20 00 14

http://www.ab-science.com

Specialty & Advanced Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AB SCIENCE	-2.04%	-0.38%	-56.86%	-78.88%	48.31M
ELI LILLY AND COMPANY	-0.11%	+9.94%	+57.20%	+148.21%	1,257B
JOHNSON & JOHNSON	-1.62%	-0.95%	+42.90%	+75.88%	651B
ABBVIE INC.	-0.98%	-0.14%	+34.93%	+102.23%	510B
ROCHE HOLDING AG	-1.56%	-1.39%	+51.02%	+64.18%	388B
MERCK & CO., INC.	-2.49%	+2.01%	+75.38%	+39.94%	366B
NOVARTIS AG	-0.02%	+3.15%	+32.47%	+55.33%	303B
ASTRAZENECA PLC	-0.72%	+7.05%	+10.34%	+32.79%	288B
AMGEN INC.	-0.90%	+2.97%	+55.67%	+70.93%	252B
GILEAD SCIENCES, INC.	-1.68%	+5.27%	+37.21%	+105.26%	211B
Average	-1.29%	+4.30%	+34.03%	+61.59%	422.67B
Weighted average by Cap.	-1.06%	+5.30%	+47.25%	+93.14%